106 related articles for article (PubMed ID: 9375749)
21. [Expression of TNF-alpha signaling adapter proteins in peripheral blood mononuclear cells in lupus nephritis patients of different TCM asthenia syndromes].
Yang X; Zhu LJ; Ji YL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):34-9. PubMed ID: 19338150
[TBL] [Abstract][Full Text] [Related]
22. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.
Ahmad M; Srinivasula SM; Wang L; Talanian RV; Litwack G; Fernandes-Alnemri T; Alnemri ES
Cancer Res; 1997 Feb; 57(4):615-9. PubMed ID: 9044836
[TBL] [Abstract][Full Text] [Related]
23. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
Shain KH; Landowski TH; Dalton WS
J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
[TBL] [Abstract][Full Text] [Related]
24. Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD.
Villunger A; Huang DC; Holler N; Tschopp J; Strasser A
J Immunol; 2000 Aug; 165(3):1337-43. PubMed ID: 10903735
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen.
Thomas LR; Stillman DJ; Thorburn A
J Biol Chem; 2002 Sep; 277(37):34343-8. PubMed ID: 12107169
[TBL] [Abstract][Full Text] [Related]
26. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
Yamada Y; Sugahara K; Tsuruda K; Nohda K; Hata T; Maeda T; Honda M; Tawara M; Hayashibara T; Joh T; Tomonaga M; Miyazaki Y; Kamihira S
Cancer Lett; 1999 Dec; 147(1-2):215-9. PubMed ID: 10660109
[TBL] [Abstract][Full Text] [Related]
27. FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface.
Ivanov VN; Lopez Bergami P; Maulit G; Sato TA; Sassoon D; Ronai Z
Mol Cell Biol; 2003 May; 23(10):3623-35. PubMed ID: 12724420
[TBL] [Abstract][Full Text] [Related]
28. The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD.
Jeong EJ; Bang S; Lee TH; Park YI; Sim WS; Kim KS
J Biol Chem; 1999 Jun; 274(23):16337-42. PubMed ID: 10347191
[TBL] [Abstract][Full Text] [Related]
29. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
30. DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain.
Cohen O; Inbal B; Kissil JL; Raveh T; Berissi H; Spivak-Kroizaman T; Feinstein E; Kimchi A
J Cell Biol; 1999 Jul; 146(1):141-8. PubMed ID: 10402466
[TBL] [Abstract][Full Text] [Related]
31. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
32. Identification of an expanded binding surface on the FADD death domain responsible for interaction with CD95/Fas.
Hill JM; Morisawa G; Kim T; Huang T; Wei Y; Wei Y; Werner MH
J Biol Chem; 2004 Jan; 279(2):1474-81. PubMed ID: 14573612
[TBL] [Abstract][Full Text] [Related]
33. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
Kim KM; Lee K; Hong YS; Park HY
Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279
[TBL] [Abstract][Full Text] [Related]
34. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Zhang J; Cado D; Chen A; Kabra NH; Winoto A
Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
[TBL] [Abstract][Full Text] [Related]
35. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
Gil J; Esteban M
Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
[TBL] [Abstract][Full Text] [Related]
36. Cytokine regulation of human intestinal primary epithelial cell susceptibility to Fas-mediated apoptosis.
Martin CA; Panja A
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G92-G104. PubMed ID: 11751162
[TBL] [Abstract][Full Text] [Related]
37. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta1 inhibits Fas-mediated apoptosis by regulating surface Fas and cFLIPL expression in human leukaemia/lymphoma cells.
Jung YJ; Kim JY; Park JH
Int J Mol Med; 2004 Jan; 13(1):99-104. PubMed ID: 14654978
[TBL] [Abstract][Full Text] [Related]
39. Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency.
van Blitterswijk WJ; Klarenbeek JB; van der Luit AH; Alderliesten MC; van Lummel M; Verheij M
Biochem J; 2009 Dec; 425(1):225-34. PubMed ID: 19824885
[TBL] [Abstract][Full Text] [Related]
40. Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells.
Tourneur L; Mistou S; Michiels FM; Devauchelle V; Renia L; Feunteun J; Chiocchia G
Oncogene; 2003 May; 22(18):2795-804. PubMed ID: 12743602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
